Core Viewpoint - Investors should closely monitor Edwards Lifesciences Corporation (EW) stock due to significant implied volatility in the options market, particularly for the Nov 21, 2025 $50.00 Put option [1] Company Analysis - Edwards Lifesciences is currently rated as Zacks Rank 3 (Hold) in the Medical - Instruments industry, which ranks in the top 37% of the Zacks Industry Rank [3] - Over the last 60 days, seven analysts have raised their earnings estimates for the current quarter, resulting in an increase of the Zacks Consensus Estimate from earnings of 59 cents per share to 61 cents per share [3] Options Market Insights - The high implied volatility suggests that options traders are anticipating a significant price movement for Edwards Lifesciences shares, potentially indicating an upcoming event that could lead to a major rally or sell-off [2][4] - Options traders often seek to sell premium on options with high implied volatility, aiming to benefit from the decay of the option's value if the underlying stock does not move as much as expected [4]
Is the Options Market Predicting a Spike in Edwards Lifesciences Stock?